Research Analysts Offer Predictions for Steris Corp.’s Q2 2018 Earnings (STE)
Steris Corp. (NYSE:STE) – Stock analysts at Northcoast Research reduced their Q2 2018 earnings per share (EPS) estimates for Steris Corp. in a report issued on Wednesday. Northcoast Research analyst D. Keiser now anticipates that the brokerage will post earnings of $1.06 per share for the quarter, down from their prior forecast of $1.07. Northcoast Research currently has a “Buy” rating on the stock. Northcoast Research also issued estimates for Steris Corp.’s Q4 2018 earnings at $1.30 EPS and FY2018 earnings at $4.49 EPS.
Steris Corp. (NYSE:STE) last released its quarterly earnings results on Tuesday, August 9th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.77 by $0.02. The company had revenue of $638.40 million for the quarter, compared to the consensus estimate of $639.04 million. Steris Corp. had a net margin of 5.52% and a return on equity of 10.72%. Steris Corp.’s revenue was up 45.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.62 earnings per share.
Separately, Zacks Investment Research raised shares of Steris Corp. from a “sell” rating to a “hold” rating in a research report on Friday, September 2nd.
Steris Corp. (NYSE:STE) traded up 0.65% during midday trading on Thursday, reaching $73.10. 622,047 shares of the company were exchanged. The firm’s 50 day moving average price is $71.34 and its 200-day moving average price is $70.24. The stock has a market capitalization of $6.30 billion, a P/E ratio of 41.99 and a beta of 1.16. Steris Corp. has a 52 week low of $61.38 and a 52 week high of $78.77.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 27th. Stockholders of record on Tuesday, August 30th were paid a dividend of $0.28 per share. This is a boost from Steris Corp.’s previous quarterly dividend of $0.25. The ex-dividend date was Friday, August 26th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.53%. Steris Corp.’s dividend payout ratio (DPR) is presently 68.71%.
In other news, VP Sudhir K. Pahwa sold 1,028 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $70.13, for a total transaction of $72,093.64. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Richard Martin Steeves sold 204,778 shares of the firm’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $71.19, for a total transaction of $14,578,145.82. Following the sale, the director now directly owns 165,434 shares in the company, valued at approximately $11,777,246.46. The disclosure for this sale can be found here. Insiders own 2.52% of the company’s stock.
Several large investors have recently modified their holdings of STE. Janus Capital Management LLC boosted its stake in shares of Steris Corp. by 28.7% in the second quarter. Janus Capital Management LLC now owns 5,022,412 shares of the company’s stock worth $345,288,000 after buying an additional 1,120,438 shares during the last quarter. Westfield Capital Management Co. LP boosted its stake in Steris Corp. by 2.2% in the second quarter. Westfield Capital Management Co. LP now owns 3,035,201 shares of the company’s stock worth $208,670,000 after buying an additional 64,702 shares in the last quarter. State Street Corp boosted its stake in Steris Corp. by 0.3% in the first quarter. State Street Corp now owns 2,687,145 shares of the company’s stock worth $190,922,000 after buying an additional 8,408 shares in the last quarter. BlackRock Institutional Trust Company N.A. boosted its stake in Steris Corp. by 2.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,426,099 shares of the company’s stock worth $172,374,000 after buying an additional 54,810 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its stake in Steris Corp. by 7.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 1,963,285 shares of the company’s stock worth $134,975,000 after buying an additional 128,956 shares in the last quarter. 91.58% of the stock is currently owned by institutional investors and hedge funds.
About Steris Corp.
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Receive News & Stock Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related stocks with our FREE daily email newsletter.